Blog

Elevate your drug development programs – The START Center for Cancer Research

Photo taken from The START Center for Cancer Research/LinkedIn

Jun 28, 2024, 15:18

Elevate your drug development programs – The START Center for Cancer Research

The START Center for Cancer Research recently shared a post on LinkedIn:

“Are you attending Tumor Models Boston this year? We hope to see you there!

Visit our booth and attend Dr. Michael Wick, Ph.D.’s presentation on July 23rd at 10 AM: “Navigating the Preclinical Oncology Landscape: The Search for Clinically Relevant PDX Models.”

Discover how XenoSTART can elevate your drug development programs with over 2,500 high-quality PDX models, representing 27+ tumor types – the broadest set of indications in the industry. Join us for a deep dive at the conference.

Schedule a meeting today.”

Source: The START Center for Cancer Research/LinkedIn
.

cancer Cancer research clinical trials drug development Michael Wick OncoDaily Oncology Oncology Conference PDX models preclinical oncology START Center for Cancer Research Tumor Models Boston XenoSTART

Isabel Rubio has been elected as the President of the European Cancer Organisation for 2026-2027

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Special Coverage